Biotech Values

[DewDiligence]

NBSE prepares for dissolution:

https://www.sec.gov/Archives/edgar/data/1173281/000110465924038432/tm249597-1_pre14a.htm

To Our Stockholders:

You are cordially invited to attend a Special Meeting of Stockholders (the “Special Meeting”) of NeuBase Therapeutics, Inc. (the “Company”) to be held on May 13, 2024, at 8:30 a.m., Eastern Time, exclusively online via live audio-only webcast.

The purpose of the Special Meeting is to approve the liquidation and dissolution of the Company (the “Dissolution”) and the Plan of Liquidation and Dissolution (the “Plan of Dissolution”), which, if approved, will authorize the Company’s Board of Directors (the “Board”) to liquidate and dissolve the Company in accordance with the Plan of Dissolution.

LOL re the faux cordialty.

NBSE is the product of a reverse-2019 merger (#msg-145848413).